Zokinvy Capsule
Product Images NDC 42358-475

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Zokinvy (NDC 42358-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sentynl Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zok00 0000 01)

Chemical structure diagram of lonafarnib, the active ingredient in Zokinvy. The structure shows molecular bonds and labeled atoms including bromine and chlorine.*

FDA Label Image

Figure 1 (Zok00 0000 02)

A Kaplan-Meier survival probability graph comparing Zokinvy (lonafarnib) treatment to untreated control over time in years. The plot shows survival probability on the vertical axis and time in years on the horizontal axis, with separate survival curves and confidence intervals for each group. Patient numbers at risk are indicated below the time axis.*

FDA Label Image

Figure (Zok00 0000 03)

An illustration showing two circular diagrams: the upper circle shows a medicine cup with volume markings at 15 mL, 10 mL, and 5 mL, and the lower circle shows a medicine spoon. The diagrams depict common household tools for measuring oral liquid medication doses.*

FDA Label Image

Figure (Zok00 0000 04)

FDA Label Image

Figure (Zok00 0000 05)

An illustration showing a hand holding a capsule, demonstrating preparation or administration instructions for an oral capsule dosage form. The image focuses on the capsule and the hand, without additional text or branding visible.*

FDA Label Image

Figure (Zok00 0000 06)

An instructional diagram labeled Figure A showing dosing options for Zokinvy capsules. The top portion depicts a measuring cup with markings at 5 mL and 10 mL accompanied by the text "Fill to either 5 mL or 10 mL." The bottom portion shows one and two teaspoons next to the text "May use 1 or 2 teaspoons of applesauce." The illustration provides guidance on liquid or applesauce administration methods.*

FDA Label Image

Figure (Zok00 0000 07)

Illustration showing options for administering medication with liquid or food. The top part depicts pouring 5 ml or 10 ml of Ora-Blend SF, Ora-Plus, or orange juice into a cup. The bottom part shows a hand placing 1 or 2 teaspoons of applesauce into a container. Both options are separated by an 'OR.'*

FDA Label Image

Figure (Zok00 0000 08)

An instructional illustration showing how to open a capsule from the prescription drug Zokinvy (lonafarnib). Figure C depicts hands holding the capsule and pulling apart the two halves. Figure D shows the capsule contents being emptied into a cup by separating the capsule halves.*

FDA Label Image

Figure (Zok00 0000 09)

An instructional illustration labeled Figure E showing a hand stirring a spoon in a glass containing a mixture. The text indicates the mixture can include Ora-Blend SF, Ora-Plus, orange juice, or applesauce.*

FDA Label Image

Figure (Zok00 0000 10)

FDA Label Image

Principal Display Panel (50 mg Carton Label)

Packaging label for Zokinvy (lonafarnib) capsules, 50 mg strength. The label shows product name, strength, and dosage form with a count of 30 capsules per package. It includes storage instructions and manufacturing information by Sentynl Therapeutics, Inc. The capsules are described as opaque yellow with imprint LNF 50. The label also lists inactive ingredients and patent information.*

FDA Label Image

Principal Display Panel (75 mg Carton Label)

The packaging label for Zokinvy (lonafarnib) capsules features the 75 mg strength in a 30-capsule carton. The label includes the brand and generic names prominently, dosage strength, and quantity. It highlights that each capsule contains 75 mg lonafarnib and lists inactive ingredients. The label also shows storage information, a barcode, and the labeler as Sentynl Therapeutics, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.